Stacy Cozad - 02 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: EVP & Chief Legal Officer
Issuer ticker: XYL
Reported as of: 02 Mar 2026
Net transaction value: +$718,419
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:58:32 UTC
Prior SEC filing: 03 Sep 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for Stacy Cozad

Key filing fact

Stacy Cozad filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.

Key facts

This page summarizes Stacy Cozad's Form 4 filing for Xylem Inc. (XYL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:58.

Change

Previous filing in this sequence was filed on 03 Sep 2025.
Current net transaction value: +$718,419.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001663264 Primary reporting owner

Cozad Stacy

Relationship: EVP & Chief Legal Officer
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Mike Nazario, by power of attorney for Stacy Cozad
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +1,563
Change %: +211%
Price: $0.000000
Shares after: 2,303
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Options (Right to Buy)

Award

Transaction value: $718,419
Shares: +5,570
Change %
Price: $128.98
Shares after: 5,570
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,570
Exercise price: $128.98
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

Footnote F2

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.